Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Jeannine
    Member
    • Sep 2009
    • 14

    #1

    Only 2% mapped reads?????

    Hey there,

    I'm currently doing basic analysis for 3 different ChIP-seq experiments, i.e.mapping (using BWA) and peak calling (MACS). All 3 samples have been processed at the same time, give approx.38million reads each (131bp reads) and the sequence quality is the same (not extremely good but alright after trimming).
    BUT, when I mapped the reads to the genome (b37), only 2% of the reads of one sample map, while I get approx.85% mapped reads with the other two samples. 2 % ???!!
    How can that happen? Any suggestions what went wrong or where the problem is? Just by looking at the sequence reads in the fastq file I can't see any problems... Any help highly appreciated!!!!
  • chadn737
    Senior Member
    • Jan 2009
    • 392

    #2
    First thing I always do when a library seems to fail that badly is blast some of the reads to make sure they actually match the organism. I have identified many problems with libraries before using this approach.

    Comment

    • gringer
      David Eccles (gringer)
      • May 2011
      • 845

      #3
      I've had a yeast sample contaminated with human samples which fitted this pattern. I got back something like 1-2% of reads mapping to yeast mRNA, and eventually discovered (after a few days of frustration) that around 70% of the reads mapped to the human genome.

      Now for mRNA reads I map to the SILVA rRNA database as something of a quality check, then give people stories about the probability of human rRNA contamination (e.g. if you accept that there was human contamination, then you also need to accept contamination from a lobster, a NZ weta, and a small bat).

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      20 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      36 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      43 views
      0 reactions
      Last Post SEQadmin2  
      Working...